Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,295.60
(
0.68%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.76
(
-0.88%
)
Bitcoin
74,032.25
(
0.12%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 72922

Tuesday, 02/10/2009 9:28:41 AM

Tuesday, February 10, 2009 9:28:41 AM

Post# of 257253
MRK presented data from Isentress' trials, all well except for 2 switch trials where the drug failed to demonstrate non-inferior virologic efficacy at maintaining viral load suppression. As a result of the viral load findings in these trials, Merck discontinued these two studies.

http://finance.yahoo.com/news/Data-from-ISENTRESSreg-Mercks-bw-14302208.html
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now